Order Article Reprints

Madi-Moussa D, Deracinois B, Teiar R, Li Y, Mihasan M, Flahaut C, Rebuffat S, Coucheney F, Drider D. Structure of Lacticaseicin 30 and Its Engineered Variants Revealed an Interplay between the N-Terminal and C-Terminal Regions in the Activity against Gram-Negative Bacteria. Pharmaceutics. 2022; 14(9):1921. https://doi.org/10.3390/pharmaceutics14091921

Madi-Moussa, Désiré, Barbara Deracinois, Radja Teiar, Yanyan Li, Marius Mihasan, Christophe Flahaut, Sylvie Rebuffat, Françoise Coucheney, and Djamel Drider. 2022. "Structure of Lacticaseicin 30 and Its Engineered Variants Revealed an Interplay between the N-Terminal and C-Terminal Regions in the Activity against Gram-Negative Bacteria" Pharmaceutics 14, no. 9: 1921. https://doi.org/10.3390/pharmaceutics14091921

Madi-Moussa, D., Deracinois, B., Teiar, R., Li, Y., Mihasan, M., Flahaut, C., Rebuffat, S., Coucheney, F., & Drider, D. (2022). Structure of Lacticaseicin 30 and Its Engineered Variants Revealed an Interplay between the N-Terminal and C-Terminal Regions in the Activity against Gram-Negative Bacteria. Pharmaceutics, 14(9), 1921. https://doi.org/10.3390/pharmaceutics14091921